Antibodies
12 January 2016
Biotest receives approval in the European Union for the early use of Zutectra® after liver transplantation12 January 2016
OncoMed Enrolls First Patient in Phase 1b Anti-RSPO3 Trial11 January 2016
Sorrento Announces Positive Data from Phase 3 studies of Biosimilar Antibodies, STI-001 and STI-0029 January 2016
Roche presents updated results for investigational cancer immunotherapy atezolizumab in advanced bladder cancer8 January 2016
Scholar Rock Announces Option Exercised by Janssen in Immuno-Oncology Collaboration Focused on Supracellular Activation8 January 2016
Progenics Pharmaceuticals Commences Pivotal Phase 3 Study of PSMA Targeted Imaging Agent 1404 for Prostate Cancer8 January 2016
Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA6 January 2016
Immunocore and GlaxoSmithKline Select First ImmTAC Clinical Candidate in Discovery Collaboration6 January 2016
Gilead Terminates Phase 2 Study of Simtuzumab in Patients With Idiopathic Pulmonary Fibrosis23 December 2015
Kamada’s Human Rabies Immune Globulin Successfully Meets Primary Endpoint in U.S. Pivotal Phase 2/3 Clinical Trial as a Post-Exposure Treatment22 December 2015
Merck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of AvelumabNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports